Cargando…
Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
INTRODUCTION: Relative to antiretroviral treatment (ART), early HIV cure-related trials (HCRTs) carry limited therapeutic benefits and unknown risks. In HCRTs requiring treatment interruption (TI) the health risks and burdens may create a barrier to study enrolment and increase the possibility for u...
Autores principales: | Arnold, Michael P, Evans, David, Vergel, Nelson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946671/ https://www.ncbi.nlm.nih.gov/pubmed/27482394 |
Ejemplares similares
-
Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017) -
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
por: Henderson, Gail E, et al.
Publicado: (2018) -
The ethical case for placebo control in HIV-cure-related studies with ART interruption
por: Magalhaes, Monica, et al.
Publicado: (2022) -
Ethical considerations for HIV cure-related research at the end of life
por: Dubé, Karine, et al.
Publicado: (2018) -
Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations
por: Zheng, Lu, et al.
Publicado: (2021)